Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Journal of Chemotherapy (Florence, Italy)|May 23, 2002
Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL) oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosagesR Debon, D Breilh, E Boselli, et al.Pathologie-Biologie|April 1, 1994
[Placental penetration of cefpirome (HR 810): study of fetal concentrations after in vitro infusions of human placenta at term]C Closse, M C Saux, D Breilh, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|October 10, 1998
Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatographyS Frappier, D Breilh, E Diarte, et al.Journal of Chemotherapy (Florence, Italy)|November 8, 2002
Diffusion of isepamicin into cancellous and cortical bone tissueE Boselli, D Breilh, J C Bel, et al.Pulmonary Pharmacology & Therapeutics|March 29, 2001
Pharmacokinetic population study to describe cefepime lung concentrationsD Breilh, M C Saux, C Delaisement, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 2000
Determination of moxifloxacin (BAY 12-8039) in plasma and lung tissue by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method with a new polymeric cartridgeT Lemoine, D Breilh, D Ducint, et al.Antimicrobial Agents and Chemotherapy|October 3, 1999
Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltrationD Breilh, B Allaouchiche, H Jaumain, et al.The Journal of Antimicrobial Chemotherapy|February 14, 2004
Diffusion of levofloxacin into bone and synovial tissuesT Rimmelé, E Boselli, D Breilh, et al.Fundamental & Clinical Pharmacology|October 16, 1999
Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approachF Odoul, C Le Guellec, J P Lamagnère, et al.Journal of Chemotherapy (Florence, Italy)|March 15, 2002
Penetration of piperacillin/tazobactam (4 g/500 mg) into synovial tissueE Boselli, D Breilh, R Debon, et al.Pageof 3